My watch list
my.chemeurope.com  
Login  

11-02-2009: Dr. Alex Valcke will be joining Arch Chemicals as Vice President, Innovation, effective November 1, 2009 and reporting to Arch Chairman, President and CEO Michael E. Campbell. In this capacity, he will work closely with Arch’s senior management team and its businesses to ensure that Arch is pursuing and investing in the best R&D efforts that support the Company’s business strategies. In addition, he will identify and drive cross-business as well as external technology opportunities.

Dr. Valcke comes to Arch after a 25-year career at Janssen Pharmaceutica NV (part of the Johnson & Johnson family of companies), where he most recently held the position of General Manager, Preservation and Material Protection Division. During his career at Janssen, he gained valuable experience as a business leader, managed key divestments and acquisitions for the division, and led a successful effort to significantly expand the company’s new product portfolio. He is also an inventor and co-inventor for several patents in the field of material protection biocides and has extensive experience in technology licensing.

Dr. Valcke graduated from the University of Ghent in Belgium with a specialty focus in microbiology, forestry engineering and wood technology. He earned his Ph.D. in Bio-engineering sciences from the University of Ghent and obtained an additional Management Education from the Vlerick Leuven Gent Management School. Among his many professional associations and accomplishments, he held senior-level positions at the International Research Group on Wood Preservation, where he became the first person from industry to be elected president.

Located in Antwerp, Belgium, Dr. Valcke will spend a substantial part of his time in the United States and at Arch technology centers and other locations around the globe.

Contact / Request information

Request further information free of charge:

Watchlist

This is where you can add this news to your personal favourites

More about Arch
  • News

    Lonza extends tender offer for all outstanding shares of Arch Chemicals common stock

    Lonza Group Ltd announced that LG Acquisition Corp., an indirect wholly owned subsidiary of Lonza, has extended the expiration date for its previously announced tender offer for 100 percent of the outstanding shares of common stock of Arch Chemicals, Inc.. The tender offer is at a price of ... more

    Lonza to acquire Arch Chemicals

    Lonza Group Ltd and Arch Chemicals, Inc. announced that they have signed an agreement pursuant to which Lonza has agreed to commence a tender offer for 100 percent of Arch Chemicals’ outstanding shares of common stock at a price of USD 47.20 per share in cash. Lonza’s offer represents a 36. ... more

    Arch Chemicals Hires Dr. Alex Valcke as Vice President, Innovation

    Dr. Alex Valcke will be joining Arch Chemicals as Vice President, Innovation, effective November 1, 2009 and reporting to Arch Chairman, President and CEO Michael E. Campbell. In this capacity, he will work closely with Arch’s senior management team and its businesses to ensure that Arch is ... more

  • Companies

    Arch Sayerlack Coatings S.r.l.

    Founded in 1954 Sayerlack set itself the goal of producing the best possible wood coatings that advanced technology could formulate. With this aim Sayerlack quickly became one of the leaders in the wood coatings industry increasing its production volumes from 50 tons in 1954 to 44517 tons i ... more

    Arch Química, S.A. de C.V.

    Innovative, Chemistry-based Solutions Driving Profitable, Global Growth Headquartered in Norwalk, Connecticut (USA), Arch Chemicals, Inc. is a global Biocides company with approximately $1.5 billion in annual sales. Together with our subsidiaries, we have 3,000 employees and manufacturing ... more

Most read news
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE